Inclusion criteria |
• Woman with a positive pregnancy test |
• Type 1 diabetes or type 2 diabetes, diagnosed prior to conception |
• Treated with unchanged basal insulin or other injectable antidiabetic treatment (for those not treated with basal insulin) for 4 weeks prior to and following conception |
• Informed consent obtained before any data collection |
Exclusion criteria |
• Women who have been pregnant for >12 weeks at baseline visit confirmed by ultrasound |